Reduction of Masseter Muscle Prominence After Treatment With OnabotulinumtoxinA: Results From a Phase 3 Double-Blind, Randomized, Placebo-Controlled Study Period in the United States

Toxicon 2026

View at publisher
Authors: Terrence Colin Keaney, Heather C Woolery-Lloyd, Jennifer Nash, M H Gold, Deanne Mraz, Rene M. Hopfinger, Reva McCaskill, Grace Pan, Catherine Foley, Xinyi Wang
DOI: 10.1016/j.toxicon.2025.108778
Cited by: 0

Fields of Study & Subjects

Botulinum Toxin and Related Neurological Disorders Myofascial pain diagnosis and treatment Pain Management and Treatment

Publication details

Journal / source
Toxicon
Volume
271
Pages
108778–108778
Publication date
8 January 2026
Language
EN